Aliquots of IPs belonging to the rapamycin treated samples were further treated with phosphatase (PPase) or not, in presence of phosphatase inhibitors (PPi) or not

Aliquots of IPs belonging to the rapamycin treated samples were further treated with phosphatase (PPase) or not, in presence of phosphatase inhibitors (PPi) or not. of substrates. Furthermore, we show that TORC1 signaling impinges on BCY1, the unfavorable regulatory subunit of PKA. Inhibition of TORC1 with rapamycin leads to BCY1 phosphorylation on several sites including T129. Phosphorylation of BCY1 T129 results in BCY1 activation and inhibition of PKA. TORC1 inhibits BCY1 T129 phosphorylation by phosphorylating and activating the S6K homolog SCH9 that in turn inhibits the MAP kinase MPK1. MPK1 phosphorylates BCY1 T129 directly. Thus, TORC1 activates PKA toward some substrates by preventing MPK1-mediated activation of BCY1. == INTRODUCTION == Cells regulate their growth in response to nutrients. To achieve this growth control, cells sense and transduce nutrient signals to coordinate several processes including transcription, ribosome biogenesis, translation, nutrient transport and metabolism, and cell morphogenesis and autophagy. InSaccharomyces cerevisiae, the TOR (Target of Rapamycin) and cAMP-dependent protein kinase A (PKA) signaling pathways are the two major pathways that transduce nutrient signals to regulate cell growth (De Virgilio and Loewith, 2006;Santangelo, Z-FA-FMK 2006;Soulardet al., 2009). TOR is found in two highly conserved and functionally distinct complexes corresponding to two effector signaling branches (Wullschlegeret al., 2006). Rapamycin-sensitive TOR Complex 1 (TORC1) mediates temporal control of cell growth in response to nutrients by promoting anabolic processes such as translation and ribosomal protein (RP) gene expression and by antagonizing catabolic processes such as Z-FA-FMK autophagy, ubiquitin-dependent protein degradation, and mRNA degradation (Crespo and Hall, 2002;Loewithet al., 2002;Reinkeet al., 2004;De Virgilio and Loewith, 2006). In addition, TORC1 regulates lifespan (Kaeberleinet al., 2005). Rapamycin-insensitive TOR Complex 2 (TORC2) mediates spatial control of cell growth by regulating actin cytoskeleton dynamics, ceramide metabolism, and cell wall integrity (De Virgilio and Loewith, 2006;Aronovaet al., 2008;Cybulski and Hall, 2009). PKA in yeast is Rabbit polyclonal to HSP90B.Molecular chaperone.Has ATPase activity. part of the RAS-cAMP signaling cascade that controls various growth-related processes in response to glucose (Santangelo, 2006). Like TORC1, the PKA pathway regulates translation, ribosome biogenesis, autophagy, stress responses, glucose metabolism, and lifespan (Santangelo, 2006). The PKA catalytic subunit is usually encoded by the three homologous and partly redundant genesTPK1,TPK2, andTPK3.The PKA regulatory subunit that controls PKA in response to cAMP is encoded byBCY1(Cannon and Tatchell, 1987;Todaet al., 1987a,b). In the absence of glucose (i.e., a fermentable carbon source), two BCY1s bind two TPKs to form a catalytically inactive heterotetrameric complex. In the presence of glucose, adenylate cyclase is usually activated and produces cAMP from ATP. cAMP in turn activates PKA by binding BCY1 and releasing it from TPK (Johnsonet al., 1987;Santangelo, 2006). Furthermore, both TPK1 and BCY1 shuttle between the cytoplasm and the nucleus in growing cells, with BCY1 mainly in the nucleus and TPK1 primarily in the cytoplasm (Griffioenet al., 2000,2001;Schmelzleet al., 2004). TORC1 and PKA regulate common target proteins to activate or inhibit the same biological processes. For example, both TORC1 and PKA regulate the nuclear localization of SFP1 and CRF1, two transcription cofactors involved in RP gene expression (Jorgensenet al., 2004;Marionet al., 2004;Martinet al., 2004;Schawalderet al., 2004;Wadeet al., 2004). Similarly, the stress-inducible transcription factors MSN2 and MSN4 are dephosphorylated and rapidly accumulate in Z-FA-FMK the nucleus upon TORC1 or PKA inhibition (Gorneret al., 1998;Beck and Hall, Z-FA-FMK 1999). Inhibition of either TORC1 or PKA also leads to the dephosphorylation, nuclear accumulation, and activation of MAF1, a repressor of RNA polymerase III (Moiret al., 2006;Huberet al., 2009;Leeet al., 2009). Seemingly conflicting models have been proposed to account for the overlapping regulation by TORC1 and PKA. According to one model, TORC1 and PKA are in distinct but parallel pathways that converge on common target proteins or processes. For example, TORC1 and PKA independently regulate MSN2 and ATG13 phosphorylation (Santhanamet Z-FA-FMK al., 2004;Stephanet al., 2009). Alternatively, several findings suggest.